Quantcast

Latest Prostate cancer Stories

2014-05-08 08:32:48

SAN DIEGO, May 8, 2014 /PRNewswire/ -- GenomeDx Biosciences announced today that the company's Decipher® Prostate Cancer Classifier will be featured in multiple sessions during the American Urological Association (AUA) Annual Meeting taking place May 16-21 in Orlando, FL. Two data presentations will detail validation studies supporting the use of Decipher to predict risk of metastasis in men following prostate surgery. Decipher has also been included in independent CME and educational...

2014-05-07 23:09:14

Survey results published today, by a Tampa Bay medical device manufacturer, BioDerm, reveal a surprising connection between music and patient’s perceptions of the side effects of prostate cancer treatment. Largo, FL (PRWEB) May 07, 2014 In a survey of more than 200 men with prostate cancer and their caregivers, BioDerm found that opera fans were more than 40% more likely than non-opera fans to report that their side effects after prostate cancer treatment were “worse” or “much...

2014-05-07 23:00:21

Mega car, truck and motorcycle show will raise funds for the Man Up Mahoning Valley Campaign to increase prostate cancer awareness and provide screenings. The event will be held Sunday, June 1, at Boardman High School in Boardman, Ohio. The event is presented by the HMHP Foundation in partnership with Sweeney Chevrolet, Buick, GMC. Boardman, OH (PRWEB) May 08, 2014 The HMHP Foundation is partnering with Sweeney Chevrolet, Buick, GMC to present the second annual Fuel the Fight: Drive Out...

2014-05-06 23:10:10

At Comprehensive Urology in Beverly Hills, urologists perform robotic-assisted prostate surgery, a method which has been shown to be more effective when treating prostate cancer. Beverly Hills, CA (PRWEB) May 06, 2014 A recent study from UCLA has found that robotic-assisted prostatectomy offers a number of advantages over traditional prostatectomy procedures. These benefits include a lower likelihood of patients needing additional treatment and fewer side effects than other prostate...

2014-05-06 16:32:54

13% Increase in Test Volume and 7% Increase in Product Revenue Compared to Prior Year REDWOOD CITY, Calif., May 6, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2014. Logo - http://photos.prnewswire.com/prnh/20130425/SF01493LOGO Product revenue was $67.0 million in the first quarter of 2014, compared with $62.7 million for the first quarter of 2013, an increase of 7 percent. Total revenue for...

2014-05-06 16:29:13

LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapieshttp://www.reportbuyer.com/pharma_healthcare/diseases/solid_tumors_market_asia_pacific_2019_new_drug_approvals_anticipated_product_launches_trigger_shift_treatment_paradigm_targeted_therapies.htmlSolid Tumors Market in Asia Pacific to...

2014-05-06 08:35:05

New Prognostic Biopsy Test Is Designed To Guide Individual Treatment Decisions About Prostate Cancer CAMBRIDGE, Mass., May 6, 2014 /PRNewswire/ -- Metamark Genetics, Inc. today announced that it has initiated clinical use of the company's ProMark(TM) prognostic test to help guide the medical management of patients with early-stage prostate cancer. ProMark(TM) is the first and only proteomic multiplex assay for intact biopsy tissue to assess the potential aggressiveness of...

2014-05-06 08:33:30

TOKYO and SAN FRANCISCO, May 6, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) to extend the indication for XTANDI® (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy. This sNDA application was granted Priority Review...

2014-05-05 23:01:21

Award Encourages Young Investigators to Take Risks in Search of a Cure Cold Spring Harbor, NY (PRWEB) May 05, 2014 The Pershing Square Sohn Cancer Research Alliance is honoring Lloyd Trotman, Associate Professor at Cold Spring Harbor Laboratory (CSHL). Trotman will receive one of six prizes for Young Investigators in Cancer Research, which seeks to fuel innovative scientific discoveries in the search for a cure for cancer. A member of the CSHL faculty since 2007, Trotman has focused on...

2014-05-05 08:28:31

New Data Include Results on Oncotype DX's Prognosis of Late Recurrence in Invasive Breast Cancer and Clinical Utility in Ductal Carcinoma In Situ (DCIS) REDWOOD CITY, Calif., May 5, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from nine studies of Oncotype DX(®) in breast, colon, prostate and renal cancer will be presented at the American Society of Clinical Oncology(®) (ASCO(®)) Annual Meeting, taking place May 30 - June 3, 2014 at McCormick Place...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related